TDOC

Teladoc Health, Inc.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002 by George Byron Brooks and is headquartered in Purchase, NY.

Teladoc Health, Inc. (TDOC) is rated C+ (2.7/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Momentum (B-); its weakest is Growth (C-). The rating has held at C+ for 2 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
2.7 / 5.0
C+
Value
C+
Factor Score 2.7 / 5.0
Growth
C-
Factor Score 2.1 / 5.0
Profitability
B-
Factor Score 2.9 / 5.0
Momentum
B-
Factor Score 3.1 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -15.9
EV / EBITDA 20.9
Rev Growth YoY -3.4%
Gross Margin 68.6%
Price Return 3M 34.6%
Price Return 12M 17.8%
Catalyst Signal 0.00
Market Cap $1.6B
TTM Revenue $2.5B
Price / Sales 0.6
ROE -11.5%

Historical Factor Score Progression

Held C+ for 2 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-11-15 C+ (2.7) C- (2.1) B- (2.9) B- (3.1) C+ (2.6) C+ (2.7)
2026-11-08 C+ (2.6) C- (1.9) B- (2.9) C+ (2.7) C+ (2.6) C+ (2.5)
2026-11-01 C+ (2.8) D+ (1.6) C+ (2.8) C+ (2.8) C+ (2.7) C+ (2.5)
2026-10-25 C+ (2.7) C- (1.9) C+ (2.8) C- (2.1) C+ (2.6) C (2.4)
2026-10-18 C+ (2.8) C- (1.9) C+ (2.8) C- (1.9) C+ (2.6) C (2.4)
Page 1 of 8
…